Analyst Price Target is $42.83
▲ +209.49% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Rhythm Pharmaceuticals in the last 3 months. The average price target is $42.83, with a high forecast of $67.00 and a low forecast of $14.00. The average price target represents a 209.49% upside from the last price of $13.84.
Current Consensus is
The current consensus among 6 contributing investment analysts is to hold stock in Rhythm Pharmaceuticals. This rating has held steady since July 2021, when it changed from a Buy consensus rating.